Cargando…

Predicting QTc Prolongation in Man From Only In Vitro Data

Mishra et al.(1) in their article “Interaction between domperidone and ketoconazole: toward prediction of consequent QTc prolongation using purely in vitro information” describe the use of physiologically based pharmacokinetic (PBPK) modeling and pharmacodynamic models of cardiac repolarization to p...

Descripción completa

Detalles Bibliográficos
Autor principal: Leishman, D J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150928/
https://www.ncbi.nlm.nih.gov/pubmed/25141222
http://dx.doi.org/10.1038/psp.2014.33
_version_ 1782332966337249280
author Leishman, D J
author_facet Leishman, D J
author_sort Leishman, D J
collection PubMed
description Mishra et al.(1) in their article “Interaction between domperidone and ketoconazole: toward prediction of consequent QTc prolongation using purely in vitro information” describe the use of physiologically based pharmacokinetic (PBPK) modeling and pharmacodynamic models of cardiac repolarization to predict clinical data from preclinical data. Eliminating the risk of cardiac arrhythmias through delayed repolarization often relies on preclinical data during compound selection. Although there are some limitations, there appears to be significant promise in using this modeling approach.
format Online
Article
Text
id pubmed-4150928
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41509282014-09-04 Predicting QTc Prolongation in Man From Only In Vitro Data Leishman, D J CPT Pharmacometrics Syst Pharmacol Commentary Mishra et al.(1) in their article “Interaction between domperidone and ketoconazole: toward prediction of consequent QTc prolongation using purely in vitro information” describe the use of physiologically based pharmacokinetic (PBPK) modeling and pharmacodynamic models of cardiac repolarization to predict clinical data from preclinical data. Eliminating the risk of cardiac arrhythmias through delayed repolarization often relies on preclinical data during compound selection. Although there are some limitations, there appears to be significant promise in using this modeling approach. Nature Publishing Group 2014-08 2014-08-20 /pmc/articles/PMC4150928/ /pubmed/25141222 http://dx.doi.org/10.1038/psp.2014.33 Text en Copyright © 2014 American Society for Clinical Pharmacology and Therapeutics http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Commentary
Leishman, D J
Predicting QTc Prolongation in Man From Only In Vitro Data
title Predicting QTc Prolongation in Man From Only In Vitro Data
title_full Predicting QTc Prolongation in Man From Only In Vitro Data
title_fullStr Predicting QTc Prolongation in Man From Only In Vitro Data
title_full_unstemmed Predicting QTc Prolongation in Man From Only In Vitro Data
title_short Predicting QTc Prolongation in Man From Only In Vitro Data
title_sort predicting qtc prolongation in man from only in vitro data
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150928/
https://www.ncbi.nlm.nih.gov/pubmed/25141222
http://dx.doi.org/10.1038/psp.2014.33
work_keys_str_mv AT leishmandj predictingqtcprolongationinmanfromonlyinvitrodata